{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T14:48:21Z","timestamp":1782658101744,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018033","name":"The University of Kansas Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20GM130423"],"award-info":[{"award-number":["P20GM130423"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["UW HN SPORE P50CA278595"],"award-info":[{"award-number":["UW HN SPORE P50CA278595"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA168524"],"award-info":[{"award-number":["P30CA168524"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006727","name":"The University of Kansas Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006727","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.canlet.2025.217690","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T05:39:54Z","timestamp":1743745194000},"page":"217690","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["MK2 promotes p16 negative head and neck cancer migration, invasion, and metastasis"],"prefix":"10.1016","volume":"622","author":[{"given":"Deri","family":"Morgan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1333-2747","authenticated-orcid":false,"given":"Dakota DD.","family":"Okwuone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5571-2270","authenticated-orcid":false,"given":"Kiersten L.","family":"Berggren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4076-5772","authenticated-orcid":false,"given":"Levi","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4845-5583","authenticated-orcid":false,"given":"Alyssa","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colby","family":"Spiess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Yada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Hendrikse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashna","family":"Madan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin","family":"Shrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Lominska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjia","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Witek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Soper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis J.","family":"McCance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sufi M.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Beebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4404-3382","authenticated-orcid":false,"given":"Sheena C.","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory N.","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.canlet.2025.217690_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients","volume":"92","author":"Pignon","year":"2009","journal-title":"Radiother. Oncol."},{"issue":"27","key":"10.1016\/j.canlet.2025.217690_bib2","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1200\/JCO.2013.53.5633","article-title":"Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: rtog 0522","volume":"32","author":"Ang","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.canlet.2025.217690_bib3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1470-2045(13)70011-1","article-title":"Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial","volume":"14","author":"Haddad","year":"2013","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.canlet.2025.217690_bib4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12094-012-0970-4","article-title":"DeCIDE and PARADIGM: nails in the coffin of induction chemotherapy in head and neck squamous cell carcinoma?","volume":"15","author":"Loo","year":"2013","journal-title":"Clin. Transl. Oncol."},{"issue":"34","key":"10.1016\/j.canlet.2025.217690_bib5","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1200\/JCO.2014.55.3925","article-title":"Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity","volume":"32","author":"Nguyen-Tan","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.canlet.2025.217690_bib6","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S1470-2045(20)30737-3","article-title":"Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial","volume":"22","author":"Lee","year":"2021","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.canlet.2025.217690_bib7","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.ijrobp.2017.06.012","article-title":"Refining patient selection for reirradiation of head and neck squamous carcinoma in the IMRT Era: a multi-institution cohort study by the MIRI collaborative","volume":"100","author":"Ward","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.canlet.2025.217690_bib8","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ijrobp.2017.04.017","article-title":"A multi-institutional comparison of SBRT and IMRT for definitive reirradiation of recurrent or second primary head and neck cancer","volume":"100","author":"Vargo","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"4","key":"10.1016\/j.canlet.2025.217690_bib9","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1200\/JCO.21.02508","article-title":"Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: updated results of the phase III KEYNOTE-048 study","volume":"41","author":"Harrington","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.canlet.2025.217690_bib10","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/hed.24687","article-title":"Distant metastases in head and neck cancer","volume":"39","author":"Duprez","year":"2017","journal-title":"Head Neck"},{"issue":"2","key":"10.1016\/j.canlet.2025.217690_bib11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/mc.23348","article-title":"Mitogen-Activated-Protein-Kinase-Activated-Protein-kinase-2 (MK2) and its role in cell survival, inflammatory signaling and migration in promoting cancer","volume":"61","author":"Morgan D","year":"2022","journal-title":"Mol. Carcinog."},{"issue":"5","key":"10.1016\/j.canlet.2025.217690_bib12","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1158\/1078-0432.CCR-12-2927","article-title":"Inactivation or loss of TTP promotes invasion in head and neck cancer via transcript stabilization and secretion of MMP9, MMP2, and IL-6","volume":"19","author":"Van Tubergen","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.canlet.2025.217690_bib13","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s10142-024-01436-6","article-title":"Long non-coding RNA MAGEA4-AS1 binding to p53 enhances MK2 signaling pathway and promotes the proliferation and metastasis of oral squamous cell carcinoma","volume":"24","author":"Wei","year":"2024","journal-title":"Funct. Integr. Genomics"},{"issue":"1","key":"10.1016\/j.canlet.2025.217690_bib14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13046-019-1167-2","article-title":"MAPKAPK2 plays a crucial role in the progression of head and neck squamous cell carcinoma by regulating transcript stability","volume":"38","author":"Soni","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217690_bib15","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.csbj.2023.01.039","article-title":"MAPKAPK2-centric transcriptome profiling reveals its major role in governing molecular crosstalk of IGFBP2, MUC4, and PRKAR2B during HNSCC pathogenesis","volume":"21","author":"Soni","year":"2023","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"48","key":"10.1016\/j.canlet.2025.217690_bib16","doi-asserted-by":"crossref","first-page":"7329","DOI":"10.1038\/s41388-019-0945-9","article-title":"MAPKAPK2 (MK2) inhibition mediates radiation-induced inflammatory cytokine production and tumor growth in head and neck squamous cell carcinoma","volume":"38","author":"Berggren","year":"2019","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.canlet.2025.217690_bib17","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/adhm.201500608","article-title":"LumeNEXT: a practical method to pattern luminal structures in ECM gels","volume":"5","author":"Jimenez-Torres","year":"2016","journal-title":"Adv. Healthcare Mater."},{"issue":"8","key":"10.1016\/j.canlet.2025.217690_bib18","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1021\/acs.jmedchem.5b01457","article-title":"Targeting mitogen-activated protein kinase-activated protein kinase 2 (MAPKAPK2, MK2): medicinal Chemistry efforts to lead small molecule inhibitors to clinical trials","volume":"59","author":"Fiore","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.canlet.2025.217690_bib19","article-title":"Discrete microfluidics for the isolation of circulating tumor cell subpopulations targeting fibroblast activation protein alpha and epithelial cell adhesion molecule","volume":"1","author":"Witek","year":"2017","journal-title":"npj Precis. Oncol."},{"issue":"5","key":"10.1016\/j.canlet.2025.217690_bib20","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"issue":"269","key":"10.1016\/j.canlet.2025.217690_bib21","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"issue":"3","key":"10.1016\/j.canlet.2025.217690_bib22","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/hed.23312","article-title":"Enhancement of head and neck squamous cell carcinoma proliferation, invasion, and metastasis by tumor-associated fibroblasts in preclinical models","volume":"36","author":"Wheeler","year":"2014","journal-title":"Head Neck"},{"issue":"23","key":"10.1016\/j.canlet.2025.217690_bib23","doi-asserted-by":"crossref","first-page":"6679","DOI":"10.1158\/0008-5472.CAN-17-1077","article-title":"Secretory autophagy in cancer-associated fibroblasts promotes head and neck cancer progression and offers a novel therapeutic target","volume":"77","author":"New","year":"2017","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.canlet.2025.217690_bib24","first-page":"603","article-title":"Activation of p38\u03b1 stress-activated protein kinase drives the formation of the pre-metastatic niche in the lungs","volume":"1","author":"Gui","year":"2020","journal-title":"Nat. Can. (Ott.)"},{"key":"10.1016\/j.canlet.2025.217690_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122136","article-title":"Microphysiological head and neck cancer model identifies novel role of lymphatically secreted monocyte migration inhibitory factor in cancer cell migration and metabolism","volume":"298","author":"Yada","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2025.217690_bib26","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ebiom.2018.10.046","article-title":"Organotypic microfluidic breast cancer model reveals starvation-induced spatial-temporal metabolic adaptations","volume":"37","author":"Ayuso","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.canlet.2025.217690_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.781535","article-title":"Microfluidic systems to study neutrophil forward and reverse migration","volume":"12","author":"Babatunde","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2025.217690_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119225","article-title":"Human organotypic lymphatic vessel model elucidates microenvironment-dependent signaling and barrier function","volume":"214","author":"Gong","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2025.217690_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103634","article-title":"Primary head and neck tumour-derived fibroblasts promote lymphangiogenesis in a lymphatic organotypic co-culture model","volume":"73","author":"Lugo-Cintr\u00f3n","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.canlet.2025.217690_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41388-019-0945-9","article-title":"MAPKAPK2 (MK2) inhibition mediates radiation-induced inflammatory cytokine production and tumor growth in head and neck squamous cell carcinoma","author":"Berggren","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.217690_bib31","article-title":"Inhibition of MK2 suppresses IL-1beta, IL-6, and TNF-alpha-dependent colorectal cancer growth","author":"Ray","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.canlet.2025.217690_bib32","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1177\/0194599812446407","article-title":"Snail controls the mesenchymal phenotype and drives erlotinib resistance in oral epithelial and head and neck squamous cell carcinoma cells","volume":"147","author":"Dennis","year":"2012","journal-title":"Otolaryngol. Head Neck Surg."},{"issue":"9","key":"10.1016\/j.canlet.2025.217690_bib33","doi-asserted-by":"crossref","first-page":"6797","DOI":"10.18632\/oncotarget.3180","article-title":"Snail and Slug collaborate on EMT and tumor metastasis through miR-101-mediated EZH2 axis in oral tongue squamous cell carcinoma","volume":"6","author":"Zheng","year":"2015","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.canlet.2025.217690_bib34","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1158\/1541-7786.MCR-11-0271","article-title":"IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway","volume":"9","author":"Yadav","year":"2011","journal-title":"Mol. Cancer Res."},{"issue":"16","key":"10.1016\/j.canlet.2025.217690_bib35","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1158\/1078-0432.CCR-17-3775","article-title":"DeltaNp63gamma\/SRC\/Slug signaling Axis promotes epithelial-to-mesenchymal transition in squamous cancers","volume":"24","author":"Srivastava","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217690_bib36","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.3389\/fonc.2019.01100","article-title":"A high-content screening approach to identify MicroRNAs against head and neck cancer cell survival and EMT in an inflammatory microenvironment","volume":"9","author":"Sangiorgi","year":"2019","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.canlet.2025.217690_bib37","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.cell.2017.10.044","article-title":"Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer","volume":"171","author":"Puram","year":"2017","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.canlet.2025.217690_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13040772","article-title":"The epithelial-mesenchymal transcription factor Slug predicts survival benefit of up-front surgery in head and neck cancer","volume":"13","author":"Riechelmann","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.canlet.2025.217690_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23095075","article-title":"Elevated LSD1 and SNAIL expression indicate poor prognosis in hypopharynx carcinoma","volume":"23","author":"Bottner","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.canlet.2025.217690_bib40","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1124\/jpet.110.166173","article-title":"A benzothiophene inhibitor of mitogen-activated protein kinase-activated protein kinase 2 inhibits tumor necrosis factor alpha production and has oral anti-inflammatory efficacy in acute and chronic models of inflammation","volume":"333","author":"Mourey","year":"2010","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"19","key":"10.1016\/j.canlet.2025.217690_bib41","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.1158\/0008-5472.CAN-18-0234","article-title":"Inhibition of the stromal p38MAPK\/MK2 pathway limits breast cancer metastases and chemotherapy-induced bone loss","volume":"78","author":"Murali","year":"2018","journal-title":"Cancer Res."},{"issue":"40","key":"10.1016\/j.canlet.2025.217690_bib42","doi-asserted-by":"crossref","first-page":"6313","DOI":"10.1038\/s41388-020-01437-2","article-title":"Her2 promotes early dissemination of breast cancer by suppressing the p38-MK2-Hsp27 pathway that is targetable by Wip1 inhibition","volume":"39","author":"Wang","year":"2020","journal-title":"Oncogene"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525002563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525002563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T03:55:58Z","timestamp":1777953358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383525002563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":42,"alternative-id":["S0304383525002563"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217690","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MK2 promotes p16 negative head and neck cancer migration, invasion, and metastasis","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217690","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"217690"}}